Skip to Content

ALV 317 (Nevirapine Extended Release 400 mg)

Pill with imprint ALV 317 is White, Capsule-shape and has been identified as Nevirapine Extended Release 400 mg. It is supplied by Alvogen Inc..

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ALV 317

Nevirapine Extended Release

Imprint:
ALV 317
Strength:
400 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alvogen Inc.
National Drug Code (NDC):
47781-0317

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide